163 related articles for article (PubMed ID: 1333960)
1. Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure.
Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1992 Oct; 22(10):662-9. PubMed ID: 1333960
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic and renal effects of urodilatin in healthy volunteers.
Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1992 May; 22(5):319-25. PubMed ID: 1317296
[TBL] [Abstract][Full Text] [Related]
3. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
[TBL] [Abstract][Full Text] [Related]
4. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men.
Saxenhofer H; Raselli A; Weidmann P; Forssmann WG; Bub A; Ferrari P; Shaw SG
Am J Physiol; 1990 Nov; 259(5 Pt 2):F832-8. PubMed ID: 2146885
[TBL] [Abstract][Full Text] [Related]
5. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
Fontana F; Guardigli G; Cappelli M; Bernardi P
G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Moe GW; Canepa-Anson R; Armstrong PW
J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
[TBL] [Abstract][Full Text] [Related]
9. Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders.
Heim JM; Gottmann K; Weil J; Schiffl H; Lauster F; Loeschke K; Gerzer R
Klin Wochenschr; 1990 Jul; 68(14):709-17. PubMed ID: 2168005
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
Carstens J; Pedersen EB
Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
[TBL] [Abstract][Full Text] [Related]
11. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
[TBL] [Abstract][Full Text] [Related]
12. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
[TBL] [Abstract][Full Text] [Related]
13. Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers.
Cusson JR; Du Souich P; Hamet P; Schiffrin EL; Kuchel O; Tremblay J; Cantin M; Genest J; Larochelle P
J Cardiovasc Pharmacol; 1988 Jun; 11(6):635-42. PubMed ID: 2457757
[TBL] [Abstract][Full Text] [Related]
14. [Urodilatin and ANF (99-126): comparison of the effects in heart failure].
Ludwig D; Kentsch M; Wiemer A; Ludwig HJ; Drummer C; Gertzer R; Müller-Esch G
Z Kardiol; 1991; 80 Suppl 8():105-6. PubMed ID: 1665627
[No Abstract] [Full Text] [Related]
15. Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations.
Firth BG; Perna R; Bellomo JF; Toto RD
Am J Med Sci; 1989 Apr; 297(4):203-8. PubMed ID: 2565086
[TBL] [Abstract][Full Text] [Related]
16. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
Cavero PG; Margulies KB; Winaver J; Seymour AA; Delaney NG; Burnett JC
Circulation; 1990 Jul; 82(1):196-201. PubMed ID: 2142023
[TBL] [Abstract][Full Text] [Related]
17. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
Margulies KB; Barclay PL; Burnett JC
Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
[TBL] [Abstract][Full Text] [Related]
18. Renal and systemic effects of urodilatin in rats with high-output heart failure.
Abassi ZA; Powell JR; Golomb E; Keiser HR
Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
[TBL] [Abstract][Full Text] [Related]
19. Effects of urodilatin in the rat kidney: comparison with ANF and interaction with vasoactive substances.
Endlich K; Forssmann WG; Steinhausen M
Kidney Int; 1995 Jun; 47(6):1558-68. PubMed ID: 7643524
[TBL] [Abstract][Full Text] [Related]
20. Effects of a bolus dose of atrial natriuretic factor in young and elderly volunteers.
Heim JM; Gottmann K; Weil J; Strom TM; Gerzer R
Eur J Clin Invest; 1989 Jun; 19(3):265-71. PubMed ID: 2553423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
